Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-01-18

FDA Approved: METHIMAZOLE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for methimazole from Upsher-Smith Laboratories, updating the labeling for the antithyroid medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methimazole (Methimazole)

Snippet

SUPPL AP for METHIMAZOLE (METHIMAZOLE)